Ryan Gonterman
About Ryan Gonterman
Ryan Gonterman is the Region Director of Oncology Field Medical at Bristol-Myers Squibb, with over a decade of experience in hematology and oncology.
Current Role as Region Director at Bristol-Myers Squibb
Ryan Gonterman currently serves as the Region Director, Oncology Field Medical at Bristol-Myers Squibb. In this leadership role, he oversees medical field operations within the oncology division, focusing on regional strategies and team management. His work involves collaborating with healthcare professionals to facilitate the integration of clinical trial data into oncology practice, ensuring that patients receive evidence-based care. This position reflects his extensive background in oncology and field medical affairs, solidifying his role within the company.
Previous Roles at Bristol-Myers Squibb
Before his current role, Ryan Gonterman was the Senior Region Associate Director, Oncology Field Medical at Bristol-Myers Squibb from 2018 to 2020, situated in Newburgh, Indiana. Prior to this, he served as the Region Associate Director, Oncology Field Medical from 2014 to 2018. He initially joined the company as a Senior Medical Science Liaison, Hematology/Oncology from 2010 to 2014. These roles provided him with progressively increasing responsibilities within the oncology and hematology sectors, highlighting his growth and expertise within the organization.
Experience at DRIVE Medical Consulting & Communications
Ryan Gonterman worked as a Senior Medical Writer at DRIVE Medical Consulting & Communications from 2008 to 2010. In this capacity, he was responsible for creating and managing medical communication materials. His work involved translating complex medical and scientific data into clear and accurate information for various stakeholders. This role strengthened his skills in medical writing and communications, which laid the foundation for his subsequent positions in the pharmaceutical industry.
Educational Background in Pharmacology and Biology
Ryan Gonterman completed his PhD in Pharmacology from Indiana University Bloomington, where he studied from 2003 to 2008. Prior to that, he earned a BA in Biology from Wabash College, studying from 1999 to 2003. His solid educational background in pharmacology and biology has equipped him with deep scientific knowledge and research skills, which he applies in his professional roles within the oncology field.